General Electric's aerospace division reported strong second-quarter 2025 earnings, with adjusted earnings per share (EPS) of $1.66 surpassing estimates of $1.43 and adjusted revenue reaching $10.15 billion, above the expected $9.59 billion. The company raised its fiscal year 2025 adjusted EPS guidance to a range of $5.60 to $5.80, slightly above the prior estimate of $5.63, and projected adjusted operating profit between $8.2 billion and $8.58 billion, up from previous forecasts. GE Aerospace also boosted its 2028 adjusted operating profit target to approximately $11.5 billion, anticipating double-digit compound annual growth in revenue from 2024 to 2028. Capital returns from 2024 to 2026 are expected to increase by 20% to $24 billion, with plans to return at least 70% of free cash flow through dividends and buybacks after 2026. Separately, GE Vernova posted Q2 revenue of $9.11 billion, an 11% year-over-year increase, and adjusted EPS of $1.86, exceeding estimates. Its order backlog grew by $5.2 billion sequentially, and it raised its full-year 2025 revenue guidance toward the high end of $36 billion to $37 billion. GE Healthcare reported second-quarter revenue of $5.00 billion, surpassing estimates, with adjusted EPS of $1.06, above the expected $0.92, and net income of $486 million. The healthcare unit raised its full-year 2025 adjusted EPS guidance to a range of $4.43 to $4.63 and expects approximately 3% organic revenue growth, up from prior guidance. Across GE's divisions, performance was driven by robust commercial services growth, improved supply chain efficiency, and strong demand in key markets including the U.S. and EMEA regions.